Found 4 hits in this display Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Alpha-1D adrenergic receptor
(Homo sapiens (Human)) | BDBM50213520
(3-(difluoromethoxy)-N-((1s,4s)-4-(4-(2-(2,2,2-trif...)Show SMILES FC(F)Oc1cccc(c1)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.92,.29,;9.38,.29,;8.6,-1.03,;8.62,1.63,;7.08,1.64,;6.32,2.99,;4.76,2.99,;3.99,1.64,;4.75,.32,;6.32,.32,;3.98,-1.02,;2.66,-.26,;5.34,-1.8,;3.23,-2.33,;1.65,-2.33,;.89,-3.65,;-.63,-3.65,;-1.4,-2.3,;-.64,-.98,;.9,-1.02,;-2.97,-2.3,;-3.74,-3.62,;-5.27,-3.62,;-6.04,-2.28,;-5.27,-.95,;-3.73,-.98,;-7.59,-2.28,;-8.37,-3.62,;-9.91,-3.62,;-10.68,-2.27,;-9.89,-.95,;-8.37,-.95,;-7.59,.4,;-8.37,1.73,;-7.6,3.07,;-6.84,4.41,;-6.26,2.3,;-8.94,3.83,)| Show InChI InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-4-3-5-22(16-21)38(34,35)32-19-8-10-20(11-9-19)33-14-12-18(13-15-33)23-6-1-2-7-24(23)36-17-26(29,30)31/h1-7,16,18-20,25,32H,8-15,17H2/t19-,20+ | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 5.90 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development L.L.C.
Curated by ChEMBL
| Assay Description
Binding affinity to human cloned adrenergic alpha1d receptor |
Bioorg Med Chem Lett 17: 3930-4 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.098
BindingDB Entry DOI: 10.7270/Q2639PF1 |
More data for this
Ligand-Target Pair | |
Alpha-1A adrenergic receptor
(Homo sapiens (Human)) | BDBM50213520
(3-(difluoromethoxy)-N-((1s,4s)-4-(4-(2-(2,2,2-trif...)Show SMILES FC(F)Oc1cccc(c1)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.92,.29,;9.38,.29,;8.6,-1.03,;8.62,1.63,;7.08,1.64,;6.32,2.99,;4.76,2.99,;3.99,1.64,;4.75,.32,;6.32,.32,;3.98,-1.02,;2.66,-.26,;5.34,-1.8,;3.23,-2.33,;1.65,-2.33,;.89,-3.65,;-.63,-3.65,;-1.4,-2.3,;-.64,-.98,;.9,-1.02,;-2.97,-2.3,;-3.74,-3.62,;-5.27,-3.62,;-6.04,-2.28,;-5.27,-.95,;-3.73,-.98,;-7.59,-2.28,;-8.37,-3.62,;-9.91,-3.62,;-10.68,-2.27,;-9.89,-.95,;-8.37,-.95,;-7.59,.4,;-8.37,1.73,;-7.6,3.07,;-6.84,4.41,;-6.26,2.3,;-8.94,3.83,)| Show InChI InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-4-3-5-22(16-21)38(34,35)32-19-8-10-20(11-9-19)33-14-12-18(13-15-33)23-6-1-2-7-24(23)36-17-26(29,30)31/h1-7,16,18-20,25,32H,8-15,17H2/t19-,20+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 7 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development L.L.C.
Curated by ChEMBL
| Assay Description
Binding affinity to human cloned adrenergic alpha1a receptor |
Bioorg Med Chem Lett 17: 3930-4 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.098
BindingDB Entry DOI: 10.7270/Q2639PF1 |
More data for this
Ligand-Target Pair | |
D(2) dopamine receptor
(Homo sapiens (Human)) | BDBM50213520
(3-(difluoromethoxy)-N-((1s,4s)-4-(4-(2-(2,2,2-trif...)Show SMILES FC(F)Oc1cccc(c1)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.92,.29,;9.38,.29,;8.6,-1.03,;8.62,1.63,;7.08,1.64,;6.32,2.99,;4.76,2.99,;3.99,1.64,;4.75,.32,;6.32,.32,;3.98,-1.02,;2.66,-.26,;5.34,-1.8,;3.23,-2.33,;1.65,-2.33,;.89,-3.65,;-.63,-3.65,;-1.4,-2.3,;-.64,-.98,;.9,-1.02,;-2.97,-2.3,;-3.74,-3.62,;-5.27,-3.62,;-6.04,-2.28,;-5.27,-.95,;-3.73,-.98,;-7.59,-2.28,;-8.37,-3.62,;-9.91,-3.62,;-10.68,-2.27,;-9.89,-.95,;-8.37,-.95,;-7.59,.4,;-8.37,1.73,;-7.6,3.07,;-6.84,4.41,;-6.26,2.3,;-8.94,3.83,)| Show InChI InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-4-3-5-22(16-21)38(34,35)32-19-8-10-20(11-9-19)33-14-12-18(13-15-33)23-6-1-2-7-24(23)36-17-26(29,30)31/h1-7,16,18-20,25,32H,8-15,17H2/t19-,20+ | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 85 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development L.L.C.
Curated by ChEMBL
| Assay Description
Binding affinity for dopamine D2 receptor |
Bioorg Med Chem Lett 17: 3930-4 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.098
BindingDB Entry DOI: 10.7270/Q2639PF1 |
More data for this
Ligand-Target Pair | |
Alpha-1B adrenergic receptor
(Homo sapiens (Human)) | BDBM50213520
(3-(difluoromethoxy)-N-((1s,4s)-4-(4-(2-(2,2,2-trif...)Show SMILES FC(F)Oc1cccc(c1)S(=O)(=O)N[C@H]1CC[C@H](CC1)N1CCC(CC1)c1ccccc1OCC(F)(F)F |wU:17.21,14.14,(10.92,.29,;9.38,.29,;8.6,-1.03,;8.62,1.63,;7.08,1.64,;6.32,2.99,;4.76,2.99,;3.99,1.64,;4.75,.32,;6.32,.32,;3.98,-1.02,;2.66,-.26,;5.34,-1.8,;3.23,-2.33,;1.65,-2.33,;.89,-3.65,;-.63,-3.65,;-1.4,-2.3,;-.64,-.98,;.9,-1.02,;-2.97,-2.3,;-3.74,-3.62,;-5.27,-3.62,;-6.04,-2.28,;-5.27,-.95,;-3.73,-.98,;-7.59,-2.28,;-8.37,-3.62,;-9.91,-3.62,;-10.68,-2.27,;-9.89,-.95,;-8.37,-.95,;-7.59,.4,;-8.37,1.73,;-7.6,3.07,;-6.84,4.41,;-6.26,2.3,;-8.94,3.83,)| Show InChI InChI=1S/C26H31F5N2O4S/c27-25(28)37-21-4-3-5-22(16-21)38(34,35)32-19-8-10-20(11-9-19)33-14-12-18(13-15-33)23-6-1-2-7-24(23)36-17-26(29,30)31/h1-7,16,18-20,25,32H,8-15,17H2/t19-,20+ | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 261 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development L.L.C.
Curated by ChEMBL
| Assay Description
Binding affinity to human cloned adrenergic alpha1b receptor |
Bioorg Med Chem Lett 17: 3930-4 (2007)
Article DOI: 10.1016/j.bmcl.2007.04.098
BindingDB Entry DOI: 10.7270/Q2639PF1 |
More data for this
Ligand-Target Pair | |